Governance and Decision Making
The Island Health Board is financially accountable for the successful delivery of IHealth, and closely monitors progress, risk management, and benefits realization.
Within the Island Health Board, an IHealth Clinical Steering Committee reviews and discusses IHealth-related materials. This steering committee, including the IHealth Executive Leads, is responsible for managing progress, risks, and benefits. The Executive Sponsors have established a Clinical Design and Operations Team (CDOT) to oversee activities and meet with IHealth leadership and project team members, including the practising clinicians and patients participating in the IHealth work streams. As the work streams and teams are established, additional project-level structures are put in place to support timely decision-making and issues management.
Clinical Standards and Practice
Clinical Working Groups, which include medical department head leaders and subject matter experts, provide the primary clinical governance vehicle for IHealth.
The Health Authority Medical Advisory Committee (HAMAC) continues to play an important role in IHealth governance, specifically related to standards and practice considerations that involve ordering providers. The HAMAC Medical Quality sub-committee reviews and recommends policy changes related to ordering providers to HAMAC and clinical working groups as appropriate.
To ensure local ownership and readiness for change, local leadership and clinical teams will make go/no-go activation decisions following completion of readiness activities and approvals by the appropriate IHealth governance bodies.
This approach ensures that local leaders are visibly leading the IHealth related changes, with the support of their local clinical teams. Depending on the activation scope and risks, HAMAC will also assess readiness and provide independent advice to the Board.
Adoption, Use, and Impact
Clinical working groups will play an important ongoing role in the oversight of adoption, use, and impact of IHealth related tools and processes, which will be critical to stabilization activities and the realization of benefits and value. Local sites and/or care teams will identify opportunities for review or improvement. Achievements and learnings will be shared through the Clinical Design and Operations Team to support awareness and spread.